Pack	Code	Status
45 mg - Soluzione Iniettabile - Uso sottocutaneo - Siringa preriempita (vetro) in penna preriempita 0.8 ml (56 mg/ml) - 1 penna preriempita	051661015	Autorizzata

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Eplontersen
Dosage form: Soluzione iniettabile in penna pre-riempita
Register: Italy (AIFA)
Status: Authorised
Status in the register: Autorizzata
Registration: AIC 051661
Marketing authorisation holder: Astrazeneca AB
ATC code: N07XX21
Group: Nervous system
Procedure: Procedura Centralizzata
Supply: Medicinali soggetti a prescrizione medica limitativa, da rinnovare volta per volta, vendibili al pubblico su prescrizione di centri ospedalieri o di specialisti